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Obesity but not overweight is associated with increased mortality
risk
Abstract
The association between body mass index (BMI) and survival has been described in various
populations. However, the results remain controversial and information from low-prevalence Western
countries is sparse. Our aim was to examine this association and its public health impact in Switzerland,
a country with internationally low mortality rate and obesity prevalence. We included 9,853 men and
women aged 25-74 years who participated in the Swiss MONICA (MONItoring of trends and
determinants in CArdiovscular disease) study (1983-1992) and could be followed up for survival until
2008 by using anonymous record linkage. Cox regression models were used to calculate mortality
hazard ratios (HRs) and to estimate excess deaths. Independent variables were age, sex, survey wave,
diet, physical activity, smoking, educational class. After adjustment for age and sex the association
between BMI and all-cause mortality was J shaped (non-smokers) or U shaped (smokers). Compared to
BMI 18.5-24.9, among those with BMI ≥ 30 (obesity) HR for all-cause mortality was 1.41 (95%
confidence interval: 1.23-1.62), for cardiovascular disease (CVD) 2.05 (1.60-2.62), for cancer 1.29
(1.04-1.60). Further adjustment attenuated the obesity-mortality relationship but the associations
remained statistically significant. No significant increase was found for overweight (BMI 25-29.9).
Between 4 and 6.5% of all deaths, 8.8-13.7% of CVD deaths and 2.4-3.9% of cancer deaths could be
attributed to obesity. Obesity, but not overweight was associated with excess mortality, mainly because
of an increased risk of death from CVD and cancer. Public health interventions should focus on
preventing normal- and overweight persons from becoming obese.
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Abstract 
The association between body mass index (BMI) and survival has been described in various 
populations. However, the results remain controversial and information from low-prevalence Western 
countries is sparse. Our aim was to examine this association and its public health impact in 
Switzerland, a country with internationally low mortality rate and obesity prevalence.  
We included 9,853 men and women aged 25-74 years who participated in the Swiss MONICA 
(MONItoring of trends and determinants in CArdiovscular disease) study (1983-1992) and could be 
followed up for survival until 2008 by using anonymous record linkage. Cox regression models were 
used to calculate mortality hazard ratios (HRs) and to estimate excess deaths. Independent variables 
were age, sex, survey wave, diet, physical activity, smoking, educational class. After adjustment for 
age and sex the association between BMI and all-cause mortality was J-shaped (non-smokers) or U-
shaped (smokers). Compared to BMI 18.5-24.9, among those with BMI ≥30 (obesity) HR for all-cause 
mortality was 1.41 (95% confidence interval: 1.23-1.62), for cardiovascular disease (CVD) 2.05 (1.60-
2.62), for cancer 1.29 (1.04-1.60). Further adjustment attenuated the obesity-mortality relationship but 
the associations remained statistically significant. No significant increase was found for overweight 
(BMI 25-29.9). Between 4% and 6.5% of all deaths, 8.8%-13.7% of CVD deaths and 2.4%-3.9% of 
cancer deaths could be attributed to obesity. Obesity, but not overweight was associated with excess 
mortality, mainly because of an increased risk of death from CVD and cancer. Public health 
interventions should focus on preventing normal- and overweight persons from becoming obese.  
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Abbreviations 
CVD Cardiovascular disease 
COPD Chronic obstructive pulmonary disease 
HR Hazard ratio 
ICD International Classification of Diseases 
ISCED International Standard Classification of Education 
SNC Swiss National Cohort 
WHO World Health Organization 
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Worldwide, the prevalence of overweight and obesity increased over the past decades and has become 
a major burden for societies. Excess weight is associated with an increased risk of disease and death, 
particularly from cardiovascular disease (CVD) and cancer [1-3]. The association between BMI and 
mortality substantially varies between populations and causes of death [1, 3-6] and can change over 
time [2, 5]. A part of this variation could be due to shortcomings originating from data assessment or 
induced in data analyses or interpretation. For example, in many studies, data is self-reported or does 
not stem from general populations but from selected groups such as physicians,[7, 8] nurses [9] or 
alumni [10]. Also, information from low-prevalence Western countries is sparse. The calculation and 
interpretation of relative risks could become critical in countries with high prevalence because the 
reference population (normal weight persons) becomes an increasingly selected minority [2]. This may 
be an explanation for the “obesity paradox”, where individuals with excess weight were found to have 
longer survival and fewer CVD events [6, 11].In many studies, the U-shape of the association between 
BMI and mortality risk was more pronounced among smokers than among non-smokers [5, 12, 13]. In 
order to estimate the independent contribution of excess weight, one should also consider that obese 
persons may differ in socioeconomic status and other lifestyle behaviours, e.g. regarding diet and 
physical activity. It is also unclear to what extent the risk associated with excess weight measured by 
BMI is accounted for by intermediate CVD risk factors such as high blood pressure and cholesterol 
level.  
We aimed at determining the risk and burden of death associated with BMI on a population level. For 
this purpose, our study population can be regarded as exceptional. Switzerland has lower mortality 
(particularly for CVD) and a lower prevalence of obesity than most other countries [14]. Obesity 
prevalence in Switzerland is about half of that of the European average, a third of that of the UK and a 
quarter of that of the US [14] [15]. BMI was based on measured weight and height, and over 90% of 
participants could be followed-up for up to 25 years. The database includes a large set of social, 
behavioural and clinical parameters thus offering the possibility to consider potential confounders or 
effect modifier in the analysis and to evaluate the independent effect of excess weight.  
 
 
Methods 
 
Study population 
Included individuals (25-74 years) were participants of the Swiss MONICA (MONItoring of trends 
and determinants in CArdiovscular disease) study. MONICA is an international multicentre project 
initiated and coordinated by the World Health Organization (WHO) [16]. In Switzerland, the study has 
been conducted in three waves between 1983 and 1992 [17, 18]. Sampled persons were invited to 
attend a health examination in their community of residence and to complete a self-administered 
questionnaire. The participation rate varied between 54 and 78% [19]. As in virtually all MONICA 
centres, no provision was made for a mortality follow-up. Recently, in Switzerland, this shortcoming 
could be overcome by an anonymous record linkage with the Swiss National Cohort (SNC) [20]. 
Details of the study population are given in Table 1. For the calculation of excess deaths attributable to 
obesity we used prevalence from two studies conducted in 2003 (measurement) and 2007 (self-report) 
[21, 22]. 
 
Record linkage procedure 
In order to determine survival, data from the SNC including information on cause of death was linked 
to MONICA participant records. The SNC encompasses all residents of Switzerland enumerated in the 
national 1990 or 2000 censuses (6.8 and 7.3 million, respectively). Deterministic and probabilistic 
methods were used to link anonymised census, death and emigration records [23]. Also, record linkage 
of MONICA and the SNC based exclusively on anonymous records [20]. 97.8% of the eligible 10,160 
MONICA participants could be linked to a census (1990: 9,737; 2000: 8,749), mortality (1,526, 1984-
2008) and/or emigration record (320, 1990-2008). 83 participants of the last wave of MONICA could 
only be linked to the preceding 1990 census but not to a subsequent census, mortality or emigration 
record, thus leaving 9,853 individuals for survival analysis. Linkage procedures and linkage success 
were described in detail [20]. 
 
Exposure variables 
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Education, lifestyle and clinical risk factors stem from MONICA. Measurements and blood sampling 
procedures have been described [17-19]. BMI was calculated from measured height (cm) and weight 
(kg) by dividing weight by height squared (kg/m2). Underweight (BMI< 18.5 kg/m2), normal weight 
(BMI 18.5 to 24.9 kg/m2), overweight (BMI 25 to 29.9 kg/m2) and obesity (≥30 kg/m2) were defined 
according to the WHO criteria[24]. 
The following educational classes were used: i) “Mandatory”: compulsory schooling (corresponding 
to completed 8th US grade) or less (International Standard Classification of Education, ISCED 1 and 
2); ii) “Secondary”: vocational training or high school (completed 12th US grade; ISCED 3); iii) 
“Tertiary”: technical college, upper vocational or university education (ISCED 5) [25, 26].  
In order to look for the risk factor variables providing the most robust results after adjustment, we 
performed sensitivity analyses with smoking status (number of cigarettes smoked daily; never, former 
and current smokers; regular smokers, occasional smokers, non-smokers), blood cholesterol (total 
cholesterol, HDL-cholesterol, ratio of total cholesterol/HDL-cholesterol), blood pressure (diastolic and 
systolic, derived four blood pressure categories, known hypertension, hypertension treatment). We 
finally selected current regular and occasional smokers and non-smokers (including former smokers). 
Construction of diet and physical activity scores is described in the annex. For separate analyses we 
used cholesterol ratio and the four blood pressure categories according to the American Heart 
Association [27].  
 
Outcome variables 
Causes of death were classified according to ICD (International Classification of Diseases) revisions 8 
(ICD-8) and 10 (ICD-10). In Switzerland ICD-8 was used until 1994 followed by ICD-10 thereafter.  
Due to the relatively small number of deaths, causes of death had to be grouped into CVD (ICD-8: 
410-438; ICD-10: I00-I99), cancer (ICD-8: 140-239; ICD-10: C00-C99; D00-D48), and non-cancer-
non-CVD (remainder).  
 
Statistical analyses 
In a first step, we performed all analyses separately by sex. We found no significant sex differences, 
neither in obesity prevalence, nor in obesity related hazard ratio (HRs). In order to obtain more robust 
estimates, we decided to pool sexes. Kaplan-Meier curves were calculated for all-cause mortality as 
well as separately for CVD, cancer and non-cancer-non-CVD, using appropriate methods to account 
for competing risks. For the estimation of HRs, we fitted a Cox regression model including relevant 
independent variables (age, sex, educational class, risk factors) and adjusting for study wave. The 
association between BMI and death was increasingly adjusted for additional variables using three 
models: 1) age, sex and survey wave; 2) + diet / physical activity scores and smoking; 3) + educational 
class. The proportional hazards assumption was tested and checked by visual inspection and seemed to 
be widely fulfilled. The methods for the calculation of population attributable fractions is described in 
the annexe. General descriptive analyses and survival estimations were performed with Stata 11 (Stata 
Corp, Texas, USA, 2009), Kaplan-Meier curves and attributable deaths were obtained with R 2.10.1 
(The R Foundation for Statistical Computing, 2009). 
 
 
Results  
 
Descriptive crude analyses 
Characteristics of participants are summarized in Table 1. The number of underweight persons was 
small and mainly consisted of women. In contrast, among obese, there were about as many women as 
men. The prevalence of obesity was higher than that based on a survey with self-reports but in line 
with that based on a study with measurement of height and weight in 2003 (Fig. 3). Obese persons 
were older, particularly when compared to normal weight participants. Between BMI categories there 
were also differences regarding educational class and smoking status. Variations in blood pressure and 
cholesterol were substantially larger than in physical activity and diet. 
 
Kaplan-Meier curves decrease when a death occurs (Fig. 1). The curves of overweight and obese 
persons decrease more rapidly than the curve of normal weight persons. However, one should consider 
that persons in the different BMI categories also differed by sex and age: normal weight persons were 
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younger and more often women. The curve of obese persons differs more strongly from the curve of 
overweight persons in CVD than in cancer deaths.  
 
 
Adjusted analyses 
Figure 2 shows HRs for all-cause mortality by BMI category in smokers (regular and occasional) and 
non-smokers (never and former). The curves have a J-shape (non-smokers) or a U-shape (smokers), 
with increased HRs at one or both extremes. Under- and normal weight smokers had in average a 
higher risk than obese non-smokers. In both groups, overweight was not associated with higher risk 
than normal weight. The increase in HRs at BMI< 20 kg/m2 was only due to an increase in men – in 
women, HRs remained fairly unchanged. However, the number of deaths was small and the 
confidence intervals were overlapping between sexes. In contrast, increase in HRs for BMI≥ 30 kg/m2 
was almost identical in men and women (sex differences not shown). The curve of the entire 
population (smokers and non-smokers combined) is shown in Figure A1. 
 
Table 2 shows all-cause and cause-specific mortality risk by BMI category. The results are adjusted 
with an increasing number of variables leading to three different models. For none of the cause of 
death groups and in none of the models, overweight was associated with increased mortality. 
Underweight tended to be associated with higher CVD but with lower cancer mortality. The number of 
cases was however small in that group. After full adjustment, mortality from all-causes among obese 
persons was 36% higher than among normal weight persons. CVD mortality was more strongly 
associated with obesity than cancer mortality. Non-cancer-non-CVD deaths were comparably more 
frequent among underweight than among normal weight individuals. In underweight persons, HRs for 
CVD and non-cancer-non-CVD deaths were higher in men than in women but the differences did not 
reach statistical significance (not shown). Generally, there were no fundamental differences between 
age groups (Table A1). In separate analyses, adjustment for cholesterol ratio and blood pressure 
substantially attenuated the association of obesity with CVD mortality by about 50%. Nevertheless, 
this association remained statistically significant. The relationship of CVD mortality with overweight 
was virtually not affected by the adjustment.  
 
Figure 3 shows deaths attributable to obesity as percentage of all deaths related to all death in the 
corresponding group (all-cause, CVD, cancer, non-cancer-non-CVD). Prevalence rates from studies 
with either self-reported (empty diamonds) or measured height and weight (filled circles) used for the 
calculation of attributable deaths are given in the legend. Due to the higher obesity prevalence, the 
proportion of attributable deaths was higher when it was based on measured height and weight: 4 % 
(self-report) and 6.5% (measurement) of all deaths were attributable to obesity. The proportions were 
higher for CVD (8.8% and 13.7% of all CVD deaths) than for cancer (2.4% and 3.9% of all cancer 
deaths).  
 
 
 
Discussion  
 
Main results 
In this general Swiss population, obesity but not overweight was associated with increased risk of 
dying from CVD and, to a smaller extent, from cancer. The relationship between BMI and all-cause 
mortality followed a J-shaped pattern in non-smokers and a U-shape pattern in smokers (Fig. 2). 
Among underweight persons, the tendency to an increased risk was driven by CVD (men) and non-
cancer-non-CVD (men and women). However, this relationship was confounded by smoking status. 
The relative risk of death associated with obesity remained significantly increased after adjustment for 
lifestyle factors and educational level (Table 2).  
 
Overweight and Obesity  
A J- or U-shaped relationship between BMI and all-cause mortality has been documented in most but 
not all cohort studies [1, 3, 13, 15, 28-32]. A more pronounced U-shape comparable to ours was found 
in a MONICA-population from Poland and in several other studies [1, 5, 12, 13, 29, 30]. The fact that 
we found no increased risk in overweight persons was at variance with reports from Korea, Europe 
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and North America and China (in persons ages <65years) [1, 13, 29, 31], but in line with other 
European studies, reports from India, the US and with results from older populations [6, 12, 15, 29, 
32-34]. In contrast to overweight, obesity was associated with increased risk of death in almost all 
available studies.  
As shown by most others and by our study, the increased mortality risk was mainly due to CVD [1, 3, 
13, 15, 29, 31, 35]: the HRs of obese vs. normal weight persons were very similar to ours [1, 13, 15, 
29, 31, 35]. In accordance with our results, no or only a marginal increase in relative CVD mortality 
risk in overweight persons was found in Poland and the US [29, 35] while a small but significant 
increase was reported in Europe and North America, China and Korea [1, 13, 29, 31]. Our relative 
risks for cancer mortality associated with obesity were somewhat higher than those found in a large 
Asian-Pacific sample [36]. This and two other samples showed a small but significant relative cancer 
risk in overweight persons, which was at odds with our finding [3, 31, 36]. In a study including 
participants from Europe and North America, the increased risk associated with higher BMI was 
substantially lower for cancer than for CVD (HR per 5 kg/m2 of increase in BMI: 1.10 vs. 1.41) [1] 
[3]. In contrast, in a large Korean population cancer and CVD mortality were similarly associated with 
obesity [31]. 
In our study, lifestyle factors and educational level only moderately attenuated excess risk of obese 
individuals. Thus, there is little evidence for uncontrolled confounding. However, in line with most 
literature a part of the CVD risk associated with obesity was apparently mediated by high blood 
pressure and cholesterol ratio [29, 31, 35]. In a meta-analysis of 21 cohort studies, almost half of the 
increased risk of fatal and nonfatal CHD events in overweight and obese persons was explained by 
higher blood pressure and cholesterol levels [37].  
Others showed that fatal and non-fatal CVD events were similarly associated with overweight and 
obesity [35]. Analogously, cancer incidence and morbidity were associated with excess weight in a 
similar manner [4]. It is therefore possible that, in Switzerland, corresponding to mortality figures, 
there is also no increased relative risk for CVD and cancer morbidity among overweight persons.  
 
Underweight  
Persons with underweight only contributed a small number of deaths and results should therefore be 
interpreted cautiously. In accordance with others, the relative risk of death of underweight persons was 
higher in smokers than in non-smokers (Fig. 2) [1, 3, 13, 31]. The tendency to higher mortality risk of 
underweight persons was driven by death from non-cancer-non-CVD. Our data did not offer sufficient 
statistical power to assess which specific causes were responsible for excess mortality in smokers and 
non-smokers. Other studies showed that respiratory mortality (e.g. COPD) substantially contributed 
[1, 13, 31, 38]. Most but not all studies showed an increased CVD mortality at BMI below 18.5 [1, 3, 
13, 29-31]. 
The association between low BMI and death could reflect insufficient consideration of early or chronic 
disease leading to both thinness and death. Our data, however, provide only little evidence for this: 
first, our population was comparably young and age did not appear to fundamentally affect the 
relationship between BMI and mortality risk (Fig. A1); second, adjustment for smoking only 
marginally attenuated estimates; third, the number of cancer deaths was negligible among underweight 
persons and the pattern (non-cancer-non-CVD > CVD > cancer) was the same as in a large study 
considering only healthy subjects who never smoked [3]. Furthermore only 3.6% and 11.9% of all 
non-injury deaths occurred during the first two and five years after study entry. Others have shown 
that  an increased risk of death in underweight persons was still observed among healthy participants 
and after exclusion of the initial 5-years of follow-up [3, 29, 39].  
 
Excess deaths attributable to obesity 
In Switzerland, nationally representative data on obesity prevalence is only available from self-reports 
which substantially underestimate real obesity prevalence [40]. For valid figures, excess deaths should 
be estimated with obesity prevalence based on measured height and weight. Since more recent data 
was not available, we used measured BMI data from 2003 for the calculation of excess deaths. 
However, this should not substantially underestimate  current excess deaths because in Switzerland 
obesity prevalence stagnated or increased only marginally since 2003 [41].  
In the US, where obesity prevalence is about twice as high as in Switzerland, approximately 29% of 
CVD deaths and 8% of cancer deaths were attributable to BMI ≥25 kg/m² [1, 11]. For the UK, the 
corresponding proportions were 23% and 6%, respectively [1, 42]. In accordance with our figures, a 
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calculation based on European data estimated that in Switzerland around 700 cancer cases per year 
could be attributed to overweight or obesity [43]. Probably, our estimates would be higher, had we 
used other markers than BMI for the definition of obesity (e.g. body fat percentage) [44]. However, a 
large European study proved BMI to remain significantly associated with the risk of death also in 
models that included waist circumference or waist-to-hip ratio [32].  
 
Public health implications 
Our findings do not support the concept that persons with overweight should decrease their BMI in 
order to reduce their risk of premature death. For this category (BMI 25-29.9) efforts aimed at 
avoiding weight gain and improving health behaviour may be more appropriate. Our study also 
implies that by controlling and treating risk factors in obese persons, excess mortality risk can be 
decreased but not eliminated. Because long term weight loss is unrealistic in obese persons, the only 
way to decrease excess deaths on a population level is to prevent persons from becoming obese. Our 
results also show that the benefit of lower BMI does not counterweight the increased risk associated 
with smoking. Thus, under- and normal weight smokers should be as consequently screened and 
motivated for smoking cessation as obese smokers.  
 
Limitations  
The MONICA participants included in our study had a lower mortality and were thus presumably 
more healthy than the general Swiss population [20]. However, in a large study conducted in an 
immediately neighbouring Austrian region, the difference between expected and observed mortality 
was even larger [13], but the observed patterns were generally the same as in our study. Obese persons 
are less likely to participate in health surveys than normal weight persons and the “healthy participant 
effect” could have distorted relative risks [45]. We also had only one measurement of height and 
weight at study entry and could not consider change in BMI during follow-up. Our obesity marker was 
restricted to BMI and did not include waist circumference, visceral fat or body fat percentage. To the 
extent that BMI imperfectly reflects adiposity, our results would tend to underestimate the deleterious 
effects of obesity [44]. Our information on diet and physical activity was based on a coarse 
assessment. However, the derived scores were significantly associated with mortality (not shown). Our 
information on pre-existing disease was restricted to known hypertension. Inclusion of this variable in 
the model only minimally affected estimates. Also for other reasons discussed above, we have little 
evidence that severe disease existing before study entry played a major role in our population. We 
found no evidence that age affected the obesity-mortality relationship. As shown in Table A1, the 
association between BMI and mortality did not fundamentally differ between the two selected age 
groups. However, the statistical power of our study was too small to allow more detailed stratification.  
 
Conclusion  
In this study from Switzerland, obesity but not overweight was associated with an increased risk of 
death. Excess mortality was driven by CVD and, to a smaller extent, by cancer. After adjustment for 
lifestyle risk factors and for educational class, the independent effect of obesity decreased but 
remained significant. Our results question the targeting of overweight individuals for weight loss 
programs in order to decrease burden of disease. In contrast, people should be prevented from 
becoming obese – irrespective of their body weight. In smokers, underweight was significantly 
associated with premature death, mainly due to non-cancer-non-CVD causes. 
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Appendices 
 
1. Diet and physical activity scores 
Diet score 
The diet score was derived from a 24h recall. The points were distributed according to the degree of 
adherence to the Mediterranean diet (maximum adherence: 8 points). With the possibilities offered by 
the available questionnaire, we adopted the scale constructed by Trichopoulou et al [46]. The points 
were distributed as follows:  
1. “Which type of fat/oil do you mainly use for the preparation of cold and warm meals?” Olive 
and canola oil for warm (0.5 point) and cold (additional 0.5 point) meals;  
2. “Which type of meat did you eat yesterday?” No red or processed meat (1 point);  
3. “Have you had fish yesterday?”, yes (1 point);  
4. “Have you had salad or crude vegetables yesterday?”, yes (0.5 point) and “Have you had 
cooked vegetable (except potatoes) yesterday?” (additional 0.5 point);  
5. “Have you had fruits yesterday?”, yes (1 point);  
6. “Have you had wholemeal bread yesterday?”, yes (1 point);  
7. ”Have you had wine, beer or cider yesterday?”, yes (1 point);  
8. “Have you had milk, cheese or other dairy products yesterday?”, no (1 point) 
 
Physical activity score 
Using questionnaire data, we created a physical activity and a diet score, both ranging between 0 
(lowest) and 8 (highest). The physical activity score was derived from the following five questions:  
1. "How much time do you use to go to work by foot or bike?": tertiles (0-2 points) were created 
from the number of minutes;  
2. "How active is your professional activity: mainly seated, 0 points, all other answers: 1 point;  
3. “How intense is your leisure time activity?" low (0 points), middle (1 point), high (2 points);  
4. "How frequent are your sports activities?": daily or several times per week (2 points), once per 
week (1 point), more rarely or never (0 points);  
5. "Is your physical activity limited because of a health problem?: yes (0 points), no (1 point).
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2. Methods: population attributable fractions 
 
The principles used to calculate population attributable fractions and excess deaths has been described 
[1, 2]. Population attributable fractions and number of excess deaths were obtained as follows: 
Separate models were fitted for underweight, overweight and obesity. Relative risks for each 
combination of categorical covariate levels were calculated from the entire MONICA data set (i.e., not 
considering the BMI category variable) with Cox regression. Using these parameters in the formulae 
[1], proportions of deaths attributable to non-reference BMI category could be obtained. Excess deaths 
for the respective BMI category were obtained by multiplying the total number of deaths registered in 
the years of two selected surveys providing the prevalence rates of the covariate combinations (2003, 
2007). Respective confidence intervals were obtained by bootstrapping. The 5th and 95th quantiles 
served as limits of the intervals. We calculated two versions, one where bootstrap samples were only 
drawn from the MONICA data set, and a second where additionally the uncertainty originating from 
the estimation of prevalence rates in the two health surveys was also taken into account. However, the 
credible intervals differed only marginally and we favoured the second version. These procedures were 
also applied for cause-specific excess deaths as described [2]. In the above mentioned publications, 
data was stratified by age group. However, our data fulfilled the proportional hazards assumption. 
Therefore, in contrast to these publications, we decided to apply the required Cox regression models to 
the entire data set. We included sex and BMI category as categorical covariates, age was used as time 
variable for the Cox regression model. We could not include other covariates in the model because of 
inconsistencies between the MONICA data and the two sets of data providing the more recent 
prevalence rates. Because the time variable (age of participants vs. time since study entry) and the 
number of included covariates differed, the results of the excess death analysis cannot directly be 
compared with those obtained from the hazard ratio calculation. In Switzerland, obesity prevalence 
rates originating from measured and self-reported height and weight differ substantially [3]. We 
therefore used self-reported (2007) [4] and measured (2003) data [5] to estimate current prevalence 
rates of all available combinations of categorical covariates. 
1. Flegal KM, Graubard BI, Williamson DF, Gail MH: Excess deaths associated with 
underweight, overweight, and obesity. Jama 2005, 293: 1861-1867. 
2. Flegal KM, Graubard BI, Williamson DF, Gail MH: Cause-specific excess deaths associated 
with underweight, overweight, and obesity. Jama 2007, 298: 2028-2037. 
3. Faeh D, Braun J, Bopp M: Underestimation of obesity prevalence in Switzerland: comparison 
of two methods for correction of self-report. Swiss Med Wkly 2009, 139: 752-756. 
4. Swiss Federal Statistical Office. Die Schweizerische Gesundheitsbefragung 2007 in Kürze 
[WWW document] URL 
http://www.bfs.admin.ch/bfs/portal/de/index/infothek/erhebungen__quellen/blank/blank/ess/0
3.Document.122331.pdf  (accessed April 2010). 2008. 
5. Firmann M, Mayor V, Vidal PM, Bochud M, Pecoud A, Hayoz D, Paccaud F, Preisig M, Song 
KS, Yuan X et al: The CoLaus study: a population-based study to investigate the 
epidemiology and genetic determinants of cardiovascular risk factors and metabolic 
syndrome. BMC Cardiovasc Disord 2008, 8:6. 
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Fig A1 All-cause mortality (hazard ratios with 95% confidence interval) in smokers and non-smokers 
combined by BMI category, adjusted for age, sex, study wave and smoking status, 9,853 participants 
of the MONICA study, 1983-92, 25-74 years at baseline 
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Table A1. Adjusted hazard ratios for all-cause mortality, by age group and BMI category, 9,853 
participants of the MONICA study, 1983-92, 25-74 years at baseline 
 
 
  
Body Mass Index* category (kg/m2) 
<18.5 18.5-24.9 25-29.9 ≥30 
  HR (95% CI) P   HR    HR (95% CI) P   HR (95% CI) P 
All cause all ages 
      Model 1 1.32 (0.87-1.99) 0.187 1.00 0.96 (0.85-1.08) 0.455 1.41 (1.23-1.62) <0.001
      Model 2 1.18 (0.78-1.80) 0.431 1.00 0.95 (0.85-1.07) 0.438 1.37 (1.19-1.58) <0.001
      Model 3 1.21 (0.80-1.85) 0.367 1.00 0.94 (0.84-1.06) 0.329 1.36 (1.18-1.56) <0.001
All cause (25-59 years) 
      Model 1 0.75 (0.31-1.82) 0.521 1.00 0.98 (0.83-1.15 0.786 1.38 (1.12-1.68) 0.003
      Model 2 0.74 (0.30-1.79) 0.498 1.00 1.01 (0.85-1.19) 0.949 1.40 (1.14-1.73) 0.001
      Model 3 0.77 (0.32-1.86) 0.557 1.00 0.98 (0.83-1.16) 0.857 1.37 (1.11-1.69) 0.003
All cause (60-74 years) 
      Model 1 1.59 (0.99-2.55) 0.054 1.00 0.95 (0.81-1.13) 0.579 1.51 (1.25-1.83) <0.001
      Model 2 1.35 (0.83-2.19) 0.232 1.00 0.92 (0.78-1.10) 0.366 1.42 (1.17-1.72) <0.001
      Model 3 1.37 (0.84-2.23) 0.205   1.00   0.92 (0.78-1.09) 0.333   1.41 (1.16-1.72) 0.001
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Figures 
 
Fig 1 Kaplan-Meier curves of normal weight, overweight and obese individuals for mortality from all 
causes (A), CVD (B), cancer (C) and non-cancer-non-CVD (D), 9,853 participants of the Swiss 
MONICA study, 1983-92, 25-74 years at baseline 
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MONICA: MONItoring of trends and determinants in CArdiovscular disease 
CVD: Cardiovascular Disease 
Body Mass index categories are based on height and weight measured at baseline 
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Fig 2 All-cause mortality (hazard ratios with 95% confidence interval) by smoking status and BMI 
category, adjusted for age, sex and study wave, 9,853 participants of the Swiss MONICA study, 1983-
92, 25-74 years at baseline 
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MONICA: MONItoring of trends and determinants in CArdiovscular disease 
Reference category are non-smokers with BMI 20.0-22.4 kg/m2 
*based on height and weight measured at baseline 
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Fig 3 Estimated excess deaths in Switzerland attributable to obesity, in percent of all causes and 
cause-specific deaths, 9,853 participants of the Swiss MONICA study, 1983-92, 25-74 years at 
baseline 
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Tables 
Table 1 Characteristics (counts, means and proportions) of the study population, by BMI category, 
9,853 participants of the Swiss MONICA study, 1983-92, 25-74 years at baseline 
              
  Body Mass Index* category (kg/m
2) 
  Total    <18.5 18.5-24.9 25 -29.9 ≥30 
Participants (n) 9853 167 4590 3789 1307
Prevalence (%) 100 1.7 46.7 38.5 13.1
Women (%) 49.6 86.2 59.6 37.1 46.0
Mean age (years) 47.2 44.7 44.4 48.9 52.0
(42.6-46.8) (44.1-44.7) (48.6-49.3) (51.4-52.6)
Mean follow-up time (years) 18.6 18.5 19.0 18.4 17.7
(17.7-19.3) (18.8-19.1) (18.3-18.6) (17.5-18.0)
Education  
   Tertiary (%) 19.3 28.9 23.9 16.2 10.9
   (21.9-35.9) (22.7-25.1) (15.0-17.1) (9.2-12.6)
   Upper secondary (%) 48.7 51.2 51.5 47.7 41.5
   (43.5-58.9) (50.0-52.9) (46.2-49.4) (38.8-44.2)
   Mandatory and secodary (%) 32.0 19.9 24.6 36.1 47.6
   (13.7-26.0) (23.4-25.9) (34.5-37.6) (44.9-50.3)
Smoking 
   Current regular (%) 28.6 31.7 32.3 26.6 21.2
   (24.6-38.9) (31.0-33.7) (25.2-28.0) (18.9-23.4)
   Current occasional (%) 4.5 3.6 4.8 4.7 2.8
   (0.7-6.4) (4.2-5.4) (4.0-5.4) (1.9-3.7)
   Non-smokers (former & never, %) 66.9 64.7 62.9 68.7 76.0
   (57.3-72.0) (61.5-64.3) (67.2-70.1) (73.7-78.4)
Mean physical activity score  3.52 3.47 3.79 3.44 2.85
   (3.17-3.77) (3.74-3.84) (3.39-3.49) (2.76-2.94)
Mean diet score 3.51 3.51 3.54 3.51 3.39
   (3.35-3.67) (3.51-3.57) (3.48-3.54) (3.34-3.44)
Blood pressure (systolic / diastolic) 
   Mean systolic (mmHg) 129.3 117.4 124.5 132.2 138.9
   (115.0-119.9) (124.0-125.0) (131.6-132.8) (137.8-139.9)
   Mean diastolic (mmHg) 78.9 71.1 76.1 80.8 84.2
   (69.7-72.6) (75.8-76.4) (80.4-81.1) (83.7-84.8)
   ≥ 140 or ≥ 90 (%) 28.8 11.4 19.0 34.6 48.6
   (6.5-16.2) (17.9-20.2) (33.1-36.1) (45.9-51.4)
Cholesterol 
   Total Cholesterol : HDL-Cholesterol (ratio) 5.06 3.79 4.42 5.52 6.15
   (3.62-3.97) (4.38-4.47) (5.46-5.58) (6.03-6.27)
   Ratio ≥ 5 (%) 44.4 13.0 28.7 56.8 67.5
   (7.8-18.3) (27.4-30.0) (55.2-58.4) (64.9-70.1)
Deaths 
   All causes (n) 1526 24 520 634 348
   Cardiovascular disease (n) 448 8 126 187 127
   Cancer (n) 636   2 232 268 134
 
* based on height and weight measured at baseline 
MONICA: MONItoring of trends and determinants in CArdiovscular disease
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Table 2 Adjusted hazard ratios for all-cause and cause specific mortality, by BMI category, 9,853 
participants of the MONICA study, 1983-92, 25-74 years at baseline 
 
  
Body Mass Index* category (kg/m2) 
<18.5 18.5-24.9 25-29.9 ≥30 
  HR (95% CI) P   HR    HR (95% CI) P   HR (95% CI) P 
All cause 
      Model 1 1.32 (0.87-1.99) 0.187 1.00 0.96 (0.85-1.08) 0.455 1.41 (1.23-1.62) <0.001
      Model 2 1.18 (0.78-1.80) 0.431 1.00 0.95 (0.85-1.07) 0.438 1.37 (1.19-1.58) <0.001
      Model 3 1.21 (0.80-1.85) 0.367 1.00 0.94 (0.84-1.06) 0.329 1.36 (1.18-1.56) <0.001
Cardiovascular disease (CVD) 
      Model 1 1.62 (0.79-3.33) 0.189 1.00 1.10 (088-1.38) 0.407 2.05 (1.60-2.63 <0.001
      Model 2 1.52 (0.74-3.13) 0.259 1.00 1.08 (0.86-1.35) 0.535 1.95 (1.52-2.51) <0.001
      Model 3 1.60 (0.77-3.29) 0.206 1.00 1.07(0.85-1.35) 0.551 1.92 (1.49-2.47) <0.001
Cancer 
      Model 1 0.26 (0.06-1.04) 0.056 1.00 0.96 (0.80-1.15) 0.647 1.29 (1.04-1.60) 0.021
      Model 2 0.24 (0.06-0.98) 0.047 1.00 0.97 (0.81-1.16) 0.711 1.28 (1.03-1.60) 0.027
      Model 3 0.25 (0.06-1.01) 0.051 1.00 0.94 (0.79-1.13) 0.519 1.25 (1.00-1.56) 0.050
Non-cancer-non-CVD 
      Model 1 2.54 (1.46-4.42) 0.001 1.00 0.86 (0.69-1.06) 0.158 1.10 (0.84-1.44) 0.488
      Model 2 2.18 (1.23-3.88) 0.008 1.00 0.86 (0.69-1.07) 0.174 1.08 (0.82-1.42) 0.576
      Model 3 2.22 (1.25-4.0) 0.006   1.00   0.86 (0.69-1.06) 0.162   1.08 (0.82-1.42) 0.585
 
 
 
Model 1 (basic): adjusted for age, sex and survey wave 
Model 2 (lifestyle): additionally adjusted for diet, physical activity and smoking 
Model 3 (socio-economic status): additionally adjusted for education 
 
*based on height and weight measured at baseline 
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